Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), talked online Thursday, Jan. 7, with the Washington University Medical Campus community about the state of the COVID-19 pandemic. The talk, part of Washington University Department of Medicine’s virtual, weekly Grand Rounds, also was available online to the public.
Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), spoke Thursday, Jan. 7, about the state of the COVID-19 pandemic as part of Washington University Department of Medicine’s virtual, weekly Grand Rounds.
Matt Miller
William G. Powderly, MD, discusses COVID-19 cases with staff in the intensive care unit at Barnes-Jewish Hospital. Powderly says that although vaccine development has been rapid, the search for therapies for patients infected with the novel coronavirus has been less successful.
A new episode of our podcast, “Show Me the Science,” has been posted. At present, these podcast episodes are highlighting research and patient care on the Washington University Medical Campus as our scientists and clinicians confront the COVID-19 pandemic.
COVID-19 vaccine development has been rapid and successful. Two vaccines that report more than 90% efficacy against the virus already are in use, with approval of more vaccines expected in the coming weeks. Meanwhile, the development of treatments for those infected with the virus has been slower. Only one drug, the steroid dexamethasone, has been proven to reduce the risk of death in those hospitalized with COVID-19. In this episode, we
December 17, 2020 SHARE Joan Niehoff, MD, receives a vaccine against COVID-19 Dec. 17 on the Medical Campus. Health-care workers and other employees in contact with patients received vaccines from the first shipment to arrive on the Medical Campus. (Photo: Matt Miller/School of Medicine)
As part of a historic effort to end the COVID-19 pandemic, health-care personnel at Washington University School of Medicine in St. Louis and BJC HealthCare have begun receiving the first doses of a vaccine against the SARS-CoV-2 virus. Almost 10,000 doses of the Pfizer vaccine will be administered in the coming weeks to School of Medicine and BJC employees who have direct contact with patients, work in patient-care areas or handle potentially infectious materials, such as nasal swab samples. Such patient-facing personnel have been prioritized by the Centers for Disease Control and Prevention (CDC) and the state of Missouri to receive the vaccine first.
A new form of an Alzheimer’s disease protein in the fluid that surrounds the brain and spinal cord indicates what stage of the disease a person is in, and tracks with tangles of tau protein in the brain, according to a new study.
Tau tangles are thought to be toxic to neurons, and their spread through the brain foretells the death of brain tissue and cognitive decline. Tangles appear as the early, asymptomatic stage of Alzheimer’s develops into the symptomatic stage.
The discovery of so-called microtubule binding region tau (MTBR tau) in the cerebrospinal fluid could lead to a way to diagnose people in the earliest stages of Alzheimer’s disease, before they have symptoms or when their symptoms are still mild and easily misdiagnosed.
Historic, hopeful moment arrives as COVID-19 vaccinations begin on Medical Campus miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.